Log in
Log in
Request trial & quote
Main Menu
Main Menu
Skip navigation
Home
Log in Biotechgate
Search website
Our offering
Business Development Database
Investor Database
Who can benefit
Big Pharma
Biotech & Medtech
CRO & CMO
Investors
Consulting & Services
Government Agencies and Industry Associations
Reports & Downloads
COVID-19 - stay informed
Biotech Financing Report
Life Science Trend Analysis
Resource Center
Industry News
Company News
Conferences
About
Who we are
Our Partners
Countries Covered
Industry Sectors Covered
Add your company
Terms of use
Contact
Log in
Request trial & quote
Main Menu
Main Menu
Skip navigation
Home
Log in Biotechgate
Search website
Our offering
Business Development Database
Investor Database
Who can benefit
Big Pharma
Biotech & Medtech
CRO & CMO
Investors
Consulting & Services
Government Agencies and Industry Associations
Reports & Downloads
COVID-19 - stay informed
Biotech Financing Report
Life Science Trend Analysis
Resource Center
Industry News
Company News
Conferences
About
Who we are
Our Partners
Countries Covered
Industry Sectors Covered
Add your company
Terms of use
Contact
Log in
Request trial & quote
Main Menu
Main Menu
Skip navigation
Home
Log in Biotechgate
Search website
Our offering
Business Development Database
Investor Database
Who can benefit
Big Pharma
Biotech & Medtech
CRO & CMO
Investors
Consulting & Services
Government Agencies and Industry Associations
Reports & Downloads
COVID-19 - stay informed
Biotech Financing Report
Life Science Trend Analysis
Resource Center
Industry News
Company News
Conferences
About
Who we are
Our Partners
Countries Covered
Industry Sectors Covered
Add your company
Terms of use
Contact
Company News in the Life Science Industry
»
Reset
↻
OSE Immunotherapeutics Receives €1.3 Million Milestone Payment from Bpifrance for OSE-127/S95011
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Related companies:
OSE Immunotherapeutics SA
Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatients
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Related companies:
Synairgen plc
AB Science announces that a new independent publication confirms that masitinib has anti-vital activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating Covid-19
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Related companies:
AllianceBernstein L.P.
Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient care
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most advanced technologies into Vithas hospitals and clinics
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Summary of the 18th Dr Julien Fundraiser
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Predictmedix Inc. - Corporate Update
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Related companies:
Peptonic Medical AB
Sweet Stuff! Doug Disraeli D.D.S. Offers Dental Health Tips for Valentine’s Day Candy
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Related companies:
Diversigen, Inc.
Patented Technology proven to ELIMINATE airborne SARS-CoV-2 (COVID-19)
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Zomedica Signs TRUFORMA™ Distribution Agreement With Miller Veterinary Supply
Read more ››
By:
GlobenewsWire
- 25 Jan 2021
Related companies:
Zomedica Corp.
KPMG announces Top 50 Biotech Enterprises in the Greater Bay Area
Innovative biotech companies in the region achieve impressive results
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
Quercis Pharma Licenses Key Patents for Thromboembolism Platform Across Cancer and COVID-19 Indications
Patents Related to P-selectin Expand Patent Life for Quercis' Investigational Drug to Prevent and Treat Venous Thromboembolism in Cancer Patients and for Prevention and Treatment of COVID-19
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
KLS Foundation Launches First-Ever Kleine Levin Syndrome Patient Registry
Patient Advocacy Group Partners with Beneufit, Inc. to Advance Rare Disease Research
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
January Therapeutics Announces Appointment of Dr. Steven Rosen as Chief Medical Advisor
As Chief Medical Advisor, Dr. Rosen will support key aspects of clinical development and patient advocacy programs.
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
Related companies:
January Therapeutics, Inc.
NEUVOGEN Appoints Dr. Christian Ottensmeier Head of Scientific Advisory Board
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
Medscape's 2021 Physician Burnout Report Finds Covid-19 Takes a Toll: Physician Happiness Plunges
Burnout Rates Highest in Female Physicians, Critical Care & Infectious Disease Specialties
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
Related companies:
Medscape Education, Medscape, LLC
Essity ranked as one of the most sustainable companies in the world
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
Related companies:
Essity Aktiebolag
New Study by the University of Calgary and Curelator Reveals Surprising Lack of Association Between Stress and Migraine
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
Piramal Pharma Solutions Announces Sterile Fill/Finish Program with Theratechnologies Inc. for TH1902 Peptide-drug Conjugate
Read more ››
By:
PR Newswire Association LLC.
- 25 Jan 2021
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
»
Explore our database of over
50,000
companies
Click to get started »
